American Healthcare REIT, Inc.
American Healthcare REIT, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Stock | 0 | 186 | 0 | -159 | 159 | 157 | -45 | 0 | 65 | 0 | 0 | 0 | |||||
Common Class T | - | - | - | - | - | 0 | 0 | -20 | 20 | 0 | 0 | 0 | |||||
Assets | |||||||||||||||||
Common Class I | - | - | - | - | - | 0 | 0 | -47 | 47 | 0 | 0 | -0 | |||||
Real Estate Investment Property Net | 4,320 | 4,183 | 3,599 | 3,346 | 3,337 | 3,367 | 3,536 | 3,510 | 3,479 | 3,425 | 3,431 | 3,483 | |||||
Held To Maturity Securities | 92 | 92 | 92 | 92 | 92 | 91 | 90 | 89 | 88 | 87 | 86 | 85 | |||||
Cash And Cash Equivalents At Carrying Value | 119 | 115 | 147 | 133 | 86 | 77 | 68 | 52 | 77 | 43 | 35 | 48 | |||||
Restricted Cash | 38 | 37 | 37 | 36 | 41 | 47 | 49 | 46 | 48 | 47 | 47 | 45 | |||||
Accounts Receivable Net | 242 | 204 | 189 | 224 | 223 | 211 | 204 | 201 | 216 | 185 | 169 | 146 | |||||
Intangible Assets Net Excluding Goodwill | 250 | 253 | 181 | 156 | 156 | 161 | 178 | 179 | 188 | 180 | 197 | 211 | |||||
Goodwill | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | |||||
Operating Lease Right Of Use Asset | 130 | 135 | 141 | 148 | 153 | 164 | 173 | 177 | 222 | 228 | 234 | 264 | |||||
Other Assets | 172 | 171 | 150 | 136 | 141 | 135 | 145 | 156 | 152 | 146 | 155 | 149 | |||||
Assets | 5,599 | 5,426 | 4,770 | 4,507 | 4,464 | 4,488 | 4,677 | 4,645 | 4,703 | 4,578 | 4,589 | 4,666 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities | |||||||||||||||||
Secured Debt | 962 | 967 | 971 | 984 | 1,000 | 982 | 1,283 | 1,229 | 1,228 | 1,302 | 1,221 | 1,238 | |||||
Line Of Credit | 550 | 550 | 0 | -93 | 643 | 689 | -187 | 234 | 550 | 1,224 | -5 | 232 | |||||
Accounts Payable And Accrued Liabilities Current A… | 340 | 318 | 298 | 274 | 272 | 258 | 270 | 254 | 257 | 243 | 234 | 224 | |||||
Off Market Lease Unfavorable | 2 | 2 | 2 | 3 | 3 | 3 | 5 | 6 | 6 | 6 | 9 | 10 | |||||
Operating Lease Liability | 131 | 136 | 141 | 148 | 154 | 165 | 174 | 179 | 220 | 226 | 231 | 263 | |||||
Liabilities | 2,077 | 2,066 | 2,050 | 2,044 | 2,159 | 2,184 | 2,420 | 2,541 | 2,561 | 3,119 | 3,055 | 3,110 | |||||
Redeemable Noncontrolling Interest Equity Fair Val… | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 34 | 60 | 60 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 5,065 | 4,880 | 4,202 | 3,958 | 3,768 | 3,720 | 3,595 | 3,279 | 3,275 | 2,548 | 2,548 | 2,547 | |||||
Retained Earnings Accumulated Deficit | -1,583 | -1,559 | -1,523 | -1,536 | -1,505 | -1,458 | -1,387 | -1,344 | -1,313 | -1,276 | -1,232 | -1,210 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -2 | -2 | -2 | -2 | -2 | -3 | -2 | -2 | -2 | -2 | -3 | -2 | |||||
Stockholders Equity | 3,482 | 3,321 | 2,678 | 2,421 | 2,304 | 2,304 | 2,257 | 2,104 | 1,961 | 1,425 | 1,474 | 1,336 | |||||
Minority Interest | 40 | 40 | 42 | 42 | 42 | 43 | 49 | 171 | 170 | 155 | 159 | 161 | |||||
Liabilities And Stockholders Equity | 5,599 | 5,426 | 4,770 | 4,507 | 4,464 | 4,488 | 4,677 | 4,645 | 4,703 | 4,578 | 4,589 | 4,666 | |||||
A2022 Credit Agreement | - | - | - | - | - | - | - | - | - | - | -16 | -52 | |||||
A2024 Credit Agreement | 550 | 0 | -525 | -93 | 643 | 0 | -72 | 118 | 550 | 1,150 | - | - | |||||
A2022 Corporate Line Of Credit | - | - | - | - | - | - | - | - | - | 915 | - | - | |||||
Revolving Credit Facility | - | - | - | - | - | - | -0 | 0 | 0 | - | -16 | -52 | |||||
Senior Unsecured Term Loan Facility | - | - | - | - | - | - | -71 | 118 | 549 | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | - | - | 0.01 | 0.01 | 0.01 | 0.01 | - | - | - | - | - | |||||
Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | |||||
Common Stock Shares Issued | 190 | - | - | - | - | - | - | - | - | - | - | - | |||||
Shares Outstanding | 190 | - | - | - | - | - | - | - | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.45% | -1.37% | 11.62% | - | - | - | - | - | - | - | - | - |
| 2025 | 0.03% | 3.26% | 7.67% | 5.63% | 4.05% | 10.04% | 2.75% | -2.97% | -5.94% | -7.91% | -4.56% | -5.03% |
| 2024 | 4.43% | 11.66% | 17.25% | 25.18% | 57.77% | 56.26% | 6.53% | 6.05% | 6.50% | -0.60% | 3.60% | 20.19% |
| 2023 | - | - | - | - | - | - | - | - | - | -0.44% | 2.34% | 6.80% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leverage & Debt | |||||||||||||||||
| Interest Coverage TTM | 0.53 | 0.09 | -0.47 | -1.29 | -1.35 | -1.29 | -1.24 | -1.23 | -1.30 | -1.44 | -1.61 | -1.68 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.53 | 0.42 | 0.18 | -0.19 | -0.25 | -0.27 | -0.24 | -0.26 | -0.46 | -1.08 | -1.43 | -1.46 | |||||
| Free Cash Flow Per Share TTM | -3.84 | -3.55 | -0.30 | 0.99 | 1.06 | 0.89 | 0.67 | 0.22 | 0.33 | 0.80 | 0.93 | 1.65 | |||||
| Dividend Per Share TTM | 0.91 | 0.98 | 0.94 | 0.94 | 0.92 | 0.93 | 0.74 | 0.63 | 0.64 | 1.15 | 1.14 | 0.97 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 15.03% | 14.37% | 11.51% | 11.20% | 12.58% | 12.20% | 17.99% | 15.53% | 12.72% | 9.97% | 9.55% | 9.15% | |||||
| Operating Profit Margin TTM | 3.55% | 2.32% | 0.42% | -1.57% | -1.94% | -1.80% | -1.68% | -1.96% | -2.93% | -4.57% | -5.77% | -6.03% | |||||
| Net Profit Margin TTM | 4.55% | 3.33% | 1.53% | -1.59% | -2.00% | -1.89% | -1.63% | -1.83% | -2.71% | -4.28% | -5.80% | -6.08% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 14.54% | 11.19% | 0.48% | 3.67% | 9.39% | 12.89% | 20.02% | 16.86% | 17.17% | 18.17% | 23.69% | 27.95% | |||||
| Net Income Growth (1Y) | -360.50% | -296.08% | -194.21% | -9.78% | -19.34% | -50.19% | -66.20% | -64.84% | -52.30% | -2.61% | 97.30% | 117.05% | |||||
| EPS Growth (1Y) | -318.23% | -254.26% | -174.55% | -26.63% | -46.39% | -74.82% | -83.30% | -82.22% | -69.80% | -2.96% | 96.62% | 116.14% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 87.63 | 110.82 | 231.65 | -188.73 | -120.01 | -100.54 | -104.11 | -53.23 | -29.97 | - | - | - | |||||
| P/B TTM | 2.53 | 2.30 | 2.61 | 2.38 | 2.01 | 1.55 | 1.48 | 0.86 | 0.73 | - | - | - | |||||
| P/S TTM | 3.99 | 3.69 | 3.55 | 3.00 | 2.40 | 1.90 | 1.70 | 0.97 | 0.81 | - | - | - | |||||
| Market Cap | 8.79B | 7.74B | 6.99B | 5.77B | 4.62B | 3.58B | 3.34B | 1.80B | 1.43B | - | - | - | |||||
| Enterprise Value | 8.67B | 7.62B | 6.84B | 5.60B | 4.49B | 3.50B | 3.27B | 1.75B | 1.31B | - | - | - | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -719.03M | -589.98M | -49.86M | 158.92M | 166.22M | 115.74M | 90.24M | 28.86M | 34.67M | 53.15M | 61.71M | 109.23M | |||||
| Net Debt | -119.38M | -114.84M | -147.36M | -169.99M | -127.45M | -76.70M | -67.85M | -52.09M | -124.53M | -43.45M | -82.16M | -93.75M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
American Healthcare REIT, Inc. (AHR) — SEC Financial Statements & Analysis
American Healthcare REIT, Inc. (AHR) is a real estate investment trusts company, incorporated in MD. American Healthcare REIT, Inc. trades on NYSE as: AHR. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), American Healthcare REIT, Inc. reported a 14.54% year-over-year revenue growth, a Gross Profit Margin of 15.03% (TTM), a Price-to-Sales (P/S) ratio of 3.99x (TTM), a Price-to-Book (P/B) ratio of 2.53 (TTM), at a market cap of $8.79B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 14.54%
- Gross Profit Margin TTM
- 15.03%
- P/S TTM
- 3.99x
- P/B TTM
- 2.53
- Market Cap
- $8.79B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is American Healthcare REIT, Inc. in?
American Healthcare REIT, Inc. (AHR) operates in the Real Estate Investment Trusts industry.
What is AHR's market cap?
American Healthcare REIT, Inc. (AHR) has a market capitalization of $8.79B as of 2026-03-31.
What is AHR's P/E ratio?
American Healthcare REIT, Inc. (AHR)'s trailing twelve month P/E ratio is 87.63x as of 2026-03-31.
What exchange does AHR trade on?
American Healthcare REIT, Inc. (AHR) trades on the NYSE.
Where is American Healthcare REIT, Inc. incorporated?
American Healthcare REIT, Inc. is incorporated in MD.